{"id":62249,"date":"2025-11-24T13:02:29","date_gmt":"2025-11-24T12:02:29","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/"},"modified":"2025-11-24T13:02:29","modified_gmt":"2025-11-24T12:02:29","slug":"bristol-myers-squibb-to-host-hematology-focused-investor-event","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/","title":{"rendered":"Bristol Myers Squibb to Host Hematology-Focused Investor Event"},"content":{"rendered":"
\n

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb<\/a> (NYSE: BMY) today announced that, following the conclusion of the American Society of Hematology (ASH) Annual Meeting and Exposition, the company will hold a virtual investor event on Thursday, December 11, 2025, to highlight key Hematology programs.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe company will host a webcast beginning at 9:00 a.m. ET, which is accessible here<\/a>. Company representatives will provide investors and analysts an overview of the company\u2019s Hematology development strategy and review recent data.\n<\/p>\n

\nA replay of the webcast will be available at http:\/\/investor.bms.com<\/a> approximately three hours after the event concludes. Materials related to the webcast will be available at http:\/\/investor.bms.com<\/a> at the start of the presentation.\n<\/p>\n

\nAbout Bristol Myers Squibb: Transforming Patients’ Lives Through Science<\/span><\/b>\n<\/p>\n

\nAt Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com<\/a> and follow us on LinkedIn<\/a>, X<\/a>, YouTube<\/a>, Facebook<\/a> and Instagram<\/a>.\n<\/p>\n

\ncorporatefinancial-news\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Relations:<\/b>
media@bms.com<\/a>\n<\/p>\n

\nInvestor Relations:<\/b>
investor.relations@bms.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that, following the conclusion of the American Society of Hematology (ASH) Annual Meeting and Exposition, the company will hold a virtual investor event on Thursday, December 11, 2025, to highlight key Hematology programs. The company will host a webcast beginning at 9:00 a.m. ET, which is … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62249","6":"format-standard","7":"category-industry"},"yoast_head":"\nBristol Myers Squibb to Host Hematology-Focused Investor Event - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bristol Myers Squibb to Host Hematology-Focused Investor Event - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that, following the conclusion of the American Society of Hematology (ASH) Annual Meeting and Exposition, the company will hold a virtual investor event on Thursday, December 11, 2025, to highlight key Hematology programs. The company will host a webcast beginning at 9:00 a.m. ET, which is ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-24T12:02:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251124331455\/en\/2041631\/22\/bms_logo_300_rgb_pos.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-to-host-hematology-focused-investor-event\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-to-host-hematology-focused-investor-event\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Bristol Myers Squibb to Host Hematology-Focused Investor Event\",\"datePublished\":\"2025-11-24T12:02:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-to-host-hematology-focused-investor-event\\\/\"},\"wordCount\":207,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-to-host-hematology-focused-investor-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251124331455\\\/en\\\/2041631\\\/22\\\/bms_logo_300_rgb_pos.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-to-host-hematology-focused-investor-event\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-to-host-hematology-focused-investor-event\\\/\",\"name\":\"Bristol Myers Squibb to Host Hematology-Focused Investor Event - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-to-host-hematology-focused-investor-event\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-to-host-hematology-focused-investor-event\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251124331455\\\/en\\\/2041631\\\/22\\\/bms_logo_300_rgb_pos.jpg\",\"datePublished\":\"2025-11-24T12:02:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-to-host-hematology-focused-investor-event\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-to-host-hematology-focused-investor-event\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-to-host-hematology-focused-investor-event\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251124331455\\\/en\\\/2041631\\\/22\\\/bms_logo_300_rgb_pos.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251124331455\\\/en\\\/2041631\\\/22\\\/bms_logo_300_rgb_pos.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-to-host-hematology-focused-investor-event\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bristol Myers Squibb to Host Hematology-Focused Investor Event\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bristol Myers Squibb to Host Hematology-Focused Investor Event - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/","og_locale":"en_US","og_type":"article","og_title":"Bristol Myers Squibb to Host Hematology-Focused Investor Event - Pharma Trend","og_description":"PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that, following the conclusion of the American Society of Hematology (ASH) Annual Meeting and Exposition, the company will hold a virtual investor event on Thursday, December 11, 2025, to highlight key Hematology programs. The company will host a webcast beginning at 9:00 a.m. ET, which is ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-24T12:02:29+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251124331455\/en\/2041631\/22\/bms_logo_300_rgb_pos.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Bristol Myers Squibb to Host Hematology-Focused Investor Event","datePublished":"2025-11-24T12:02:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/"},"wordCount":207,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251124331455\/en\/2041631\/22\/bms_logo_300_rgb_pos.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/","url":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/","name":"Bristol Myers Squibb to Host Hematology-Focused Investor Event - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251124331455\/en\/2041631\/22\/bms_logo_300_rgb_pos.jpg","datePublished":"2025-11-24T12:02:29+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251124331455\/en\/2041631\/22\/bms_logo_300_rgb_pos.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251124331455\/en\/2041631\/22\/bms_logo_300_rgb_pos.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-to-host-hematology-focused-investor-event\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bristol Myers Squibb to Host Hematology-Focused Investor Event"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62249"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62249\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}